- Home
- MOGO vs LSTA Comparison
MOGO vs LSTA Comparison
Compare MOGO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- LSTA
- Stock Information
- Founded
- MOGO 2003
- LSTA 1980
- Country
- MOGO Canada
- LSTA United States
- Employees
- MOGO N/A
- LSTA N/A
- Industry
- MOGO
- LSTA Misc Health and Biotechnology Services
- Sector
- MOGO
- LSTA Health Care
- Exchange
- MOGO Nasdaq
- LSTA Nasdaq
- Market Cap
- MOGO 24.5M
- LSTA 24.2M
- IPO Year
- MOGO N/A
- LSTA N/A
- Fundamental
- Price
- MOGO $1.29
- LSTA $2.85
- Analyst Decision
- MOGO Strong Buy
- LSTA Strong Buy
- Analyst Count
- MOGO 1
- LSTA 1
- Target Price
- MOGO $6.00
- LSTA $15.00
- AVG Volume (30 Days)
- MOGO 144.6K
- LSTA 15.2K
- Earning Date
- MOGO 11-06-2024
- LSTA 11-12-2024
- Dividend Yield
- MOGO N/A
- LSTA N/A
- EPS Growth
- MOGO N/A
- LSTA N/A
- EPS
- MOGO N/A
- LSTA N/A
- Revenue
- MOGO $30,995,226.00
- LSTA N/A
- Revenue This Year
- MOGO N/A
- LSTA N/A
- Revenue Next Year
- MOGO $12.48
- LSTA N/A
- P/E Ratio
- MOGO N/A
- LSTA N/A
- Revenue Growth
- MOGO N/A
- LSTA N/A
- 52 Week Low
- MOGO $0.94
- LSTA $2.05
- 52 Week High
- MOGO $2.25
- LSTA $3.83
- Technical
- Relative Strength Index (RSI)
- MOGO 57.39
- LSTA 46.05
- Support Level
- MOGO $0.95
- LSTA $2.75
- Resistance Level
- MOGO $1.95
- LSTA $2.94
- Average True Range (ATR)
- MOGO 0.13
- LSTA 0.21
- MACD
- MOGO 0.04
- LSTA -0.01
- Stochastic Oscillator
- MOGO 34.65
- LSTA 23.08
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.